FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.
What is Fsd Pharma's quote symbol?
What is the 52 week high and low for Fsd Pharma (NASDAQ: HUGE)?
How much is Fsd Pharma stock worth today?
How much is Fsd Pharma's stock price per share?
What is Fsd Pharma's Market Cap?